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Objectives. This study investigated the influence of early spon- 
taneous intermittent reperfusion on the extent of myocardial 
damage and its relation to endogenous hemostatic activity. 
Background. In the early phase of acute myocardial infarction 
coronary occlusion is often intermittent, even before thrombolytic 
therapy is administered. The relation between this phenomenon, 
myocardial damage and hemostatic activity is unknown. 
Methods. Holter ST segment recording and pretreatment 
plasma tissue-type plasminogen activator (t-PA) antigen, plas- 
minogen activator inhibitor-1 (PM-1) antigen, prothrombin frag- 
ment F1 +2 and soluble fibrin levels were measured in57 patients 
with acute evolving myocardial infarction. Spontaneous intermit- 
tent myocardial reperfusion, defined as two or more episodes of 
transient resolution of ST segment elevation to within 0.05 mV of 
baseline, lasting >1 min, before the start of recombinant t-PA 
(rt-PA) treatment was present in 28 patients (group 1) and absent 
in 29 (group 2). Left ventriculography and coronary angiography 
were performed 90 rain after intravenous rt-PA administration. 
Plasma creatine kinase.MB fraction (CK.MB) levels were mea- 
sured every 6 h for 24 h, and C-reactive protein levels were 
measured aily for 3 days. 
Results. Group 1 had lower peak plasma CK-MB (141.9 -+ 28.3 
vs. 203.8 -+ 23.3 IU/liter [mean -+ SEM], p < 0.014) and 
C-reactive protein levels (16 -+ 4 vs. 28 - 4 mg/liter on day 1; 
26.6 -+ 5.5 vs. 61.8 +- 14.4 mg/liter on day 2; 19.6 +- 4.2 vs. 40.6 -+ 
6.5 mg/liter on day 3, p < 0.012) and a higher left ventricular 
ejection fraction (62.9 "4" 4% vs. 51.1 -+ 5%, p < 0.04) than group 
2. Group 1 had lower plasma t-PA antigen levels (15.6 vs. 27 
/tg/iiter, p < 0.006) but higher prothrombin fragment Fl+2 (1.8 
vs. 1.1 nmol/liter, p < 0.003) and soluble fibrin levels (66.8 vs. 31 
nmol/liter, p < 0.01). Coronary patency at 90 min was similar. 
Conclusions. Early spontaneous intermittent reperfusion dur- 
ing acute myocardial infarction is associated with augmented 
thrombogenic activity and less subsequent myocardial damage. 
This finding is consistent with a protective ffect of intermittency 
on the myocardium and a procoagulant effect of spontaneous lysis 
on blood. It may also reflect a different rate of evolution of 
coronary thrombosis and myocardial infarction in patients with 
and those without spontaneous intermittent myocardial reperfu- 
sion. 
(J Am Coil Cardiol 1995;26:662-7) 
Thrombus formation is the main mechanism of obstruction of 
the coronary artery during acute myocardial infarction (1), and 
in the early phase, before treatment is given, spontaneous 
closure and reopening of the artery with its associated inter- 
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mittent ischemia nd reperfusion, is common (2,3). The mech- 
anism of this spontaneous intermittent reperfusion is un- 
known. However, there is evidence that acute coronary reper- 
fusion induced by thrombolytic therapy is thrombogenic (4,5). 
Furthermore, animal studies have shown (6-8) that short 
transient episodes of myocardial ischemia can "precondition" 
the myocardium such that it is rendered more resistant o 
subsequent episodes of sustained myocardial ischemia. Myo- 
cardial protection has been demonstrated (9,10) in patients 
subjected to brief periods of intermittent ischemia nd reper- 
fusion during percutaneous coronary angioplasty and coronary 
artery bypass urgery. 
In the present study we investigated the hemostatic system 
and the extent of myocardial damage in patients with acute 
myocardial infarction with and without spontaneous intermit- 
tent reperfusion. 
C,1995 by the American College ~)1 Cal-di~+>g? 0735-1097/95/$9.50 
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Methods  
Patients. Fifty-seven consecutive patients atisfying the in- 
clusion criteria were enrolled in a study of three different 
thrombolytic treatment regimens using recombinant tissue- 
type plasminogen activator (rt-PA). The inclusion criteria were 
chest pain lasting between 30 rain and 6 h and electrocardio- 
graphic (ECG) changes of early evolving acute myocardial 
infarction (ST segment elevation >0.2 mV in at least two 
contiguous leads of the 12-lead ECG) refractory to a 2-rag 
intravenous bolus of isosorbide dinitrate. Patients with cardio- 
genie shock, contraindications to thrombolytic therapy and 
age >75 years were excluded. The study was approved by the 
Hammersmith Hospital Research Ethics Committee, and all 
patients gave written informed consent. 
Protocol. A continuous 24-h ECG recording (Marquette 
8000 AM recorder) of the two leads showing the greatest ST 
segment elevation was started. An intravenous infusion of 1 to 
10 mg/h of isosorbide dinitrate, titrated against blood pressure, 
was commenced and continued for 24 h. A venous blood 
sample was taken by direct venipuncture after minimal venos- 
tasis for assay of creatine kinase, myocardial isoenzyme frac- 
tion (CK-MB), C-reactive protein, prothrombin fragment 
F 1 + 2, soluble fibrin, plasminogen activator inhibitor- 1(PAI- 1) 
and t-PA antigen levels. An intravenous bolus of heparin 
(5,000 IU) was administered. Coronary angiography was per- 
formed, and double-chain rt-PA (Wellcome Foundation, Beck- 
enham, United Kingdom) was administered intravenously 
within 6 h of onset of pain. 
The dose of rt-PA is expressed inclot-lysis megaunits (MU) 
of active protein (11). As part of a study of three different 
rt-PA regimens, the drug was administered according to one of 
the following schedules: 1) as a continuous infusion of 40 MU 
over 90 min, followed by 4 MU/h over the next 5 h (n = 12); 
2) as four rapid boluses of 10 MU each, given every 20 min 
over 1 h, with no subsequent i fusion (n = 14); or 3) as a single 
rapid bolus of 0.30 to 0.6 MU/kg body weight (n = 31). 
Coronary angiography was repeated 90 rain after the start of 
rt-PA administration, and single-plane left ventriculography 
was performed in the 30 o right anterior oblique projection. 
Heparin infusion was then commenced, to achieve an activated 
partial thromboplastin time between two and three times 
control value, and continued for 24 h. Aspirin, 300 mg daily, 
and diltiazem, 60 mg every 8 h orally, were started immediately 
after angiography. Further blood samples for C-reactive pro- 
tein were taken at precisely 24, 48 and 72 h from the time of 
entry to the study. Samples were taken every 6 h over the first 
24 h for determination f CK-MB levels. 
Data analysis. STsegment monitoring. The 24-h continuous 
ECG recordings were analyzed using the Marquette 8000 laser 
system. A marker indicating the start of rt-PA administration 
was located. Spontaneous intermittent recanalization f coro- 
nary arteries was defined as two or more episodes of transient 
resolution of ST segment elevation to within 0.05 mV of 
baseline, lasting -> 1 rain and occurring before the start of rt-PA 
treatment. Time of resolution of maximal sustained ST eleva- 
tion to 50%, measured from the onset of rt-PA treatment, was 
taken as an indirect assessment of recanalization time (12). 
The duration of persistent ischemia was measured from the 
point at which 50% of the ST segment elevation had resolved 
after rt-PA administration to baseline (onset of Holter moni- 
toring) or to that at the last episode of ST segment reelevation 
in patients howing early intermittent ST segment elevation. 
Blood samples andplasma assays. After discard of the first 
2 ml of blood, 9 ml were transferred to cooled plastic tubes 
containing 1 ml of 0.109 mol/liter of trisodium citrate. Platelet- 
poor plasma was obtained by cold (4°C) centrifugation at
1,300g for 20 min. Plasma liquots were snap-frozen within 1 h 
of blood collection and stored at -70°C. 
The CK-MB activity level was measured kinetically after 
immunoinhibition (MB CK NAC-activity kit, Boehringer 
Mannheim, Lewes, United Kingdom) and expressed in 
IU/liter. The C-reactive protein concentrations were deter- 
mined by immunoturbidimetric assay (RA-1000 analyzer, 
Bayer Diagnostics method SM4-0183B87, Basingstokc, United 
Kingdom) and expressed in mg/qiter. Plasma concentrations 
of prothrombin fragment F1+2 (nmol/liter), t-PA antigen 
(/zg/liter) and PAI-1 (~g/liter) were measured by enzyme- 
linked immunosorbent assays using commercially available kits 
(Enzygnost Fl+2, Behring, Behringwerke, Marburg, Ger- 
many; Imulyse t-PA, Biopool, Umea, Sweden; and TintElize 
PAI-1, Biopool, Umea, Sweden). Soluble fibrin concentrations 
(nmol/liter) were measured using a commercially available 
functional assay (Coa-set fibrin monomer, KabiVitrum, Am- 
sterdam, The Netherlands). 
Coronary angiography and left ventriculography. Patency 
of the infarct-related artery was assessed by two independent 
observers according to Thrombolysis n Myocardial Infarction 
(TIMI) perfusion criteria (13). Coronary occlusion was defined 
as TIMI grade 0 or 1 andpatency as TIMI grade 2 or 3. Subtotal 
occlusion was defined as the presence of arteriographic f lling 
defects suggestive of intraluminal thrombus despite TIMI 
grade 2 or 3. For each patient collateral filling of the occluded 
infarct-related artery was also noted. 
End-diastolic volume (EDVI) and end-systolic volume in- 
dexes (ESVI) were calculated by computer from automated 
traced silhouettes of the left ventriculogram according to the 
regional contribution to ejection fraction method (Computer- 
ized analysis with Pie Medical Analysis System) (14,15). Ejec- 
tion fraction was determined as100 x (EDVI - ESVI)/EDVI. 
Statistical analysis. Data are expressed as mean value _+ 
SEM, unless otherwise stated. The Wilcoxon signed rank test 
and Mann-Whitney test were used to compare paired or 
unpaired ata as appropriate. Discrete data were analyzed by 
the chi-square test. Significance was defined as p < 0.05. A 
mixed-model analysis of variance was used to compare CK-MB 
and C-reactive protein values between groups and postthrom- 
bolysis time points. The presence of an interaction effect 
between group and time was also tested for. The data were log 
transformed so that the assumptions of analysis of variance 
were valid. 
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Figure 1. Examples of the pattern of ST segment change from a 
patient in group 1 (top) and two patients in group 2 (middle and 
bottom). A continuous plot of ST segment level (60 ms after the J point 
[mean 3 +_ I rain]) against ime from admission to hospital is shown. 
Top, Three episodes of ST segment elevation, followed by resolution to 
baseline (indicating intermittent closure and reopening of the infarct- 
related coronary artery), precede a period of sustained ST segment 
elevation of ~30 min. The sustained ST segment elevation resolves 
almost o baseline after thrombolytic therapy (arrow). Middle, Con- 
tinuous ST segment elevation for - I  h from admission (indicating 
persistent infarct-related artery occlusion) that resolves after throm- 
bolytic therapy has been administered (arrow). Bottom, Retrospective 
analysis reveals a period of sustained ST segment elevation, beginning 
after hospital admission (indicating the development of persistent 
occlusion of the infarct-related artery) and lasting -40 min. It is not 
preceded by intermittent occlusion and reperfusion and resolves to 
baseline after the start of thrombolytic therapy. 
Results 
Patient characteristics. Fifty-seven consecutive patients 
satisfying the inclusion criteria completed the study. A mean of 
24 ± 2 h/patient of continuous ST segment monitoring was 
available for analysis. Twenty-eight patients (49%) showed 
intermittent ST segment elevation and resolution before sus- 
tained, continuous ST segment elevation (group 1) before 
initiation of thrombolytic treatment, indicating spontaneous 
intermittent reperfusion; and 29 patients (51%) exhibited 
continuous ST segment elevation with no such preceding 
intermittent ST segment elevation (group 2) (Fig. 1). Duration 
of Holter monitoring before the start of lytic therapy was 
150 +_ 56 min in group I and 160 _+ 75 rain in group 2 (p < 0.5). 
Duration of continuous persistent ST segment elevation/ 
patient was 323 _+ 54 rain in group 1 and 454 _+ 98 rain in group 
2 (p < 0.3). Maximal ST segment elevation was less in group 1 
(0.37 _+ 0.05 mV) than in group 2 (0.6 ± 0.11 mV) (p < 0.03). 
In group 1, there were 4 +_ 0.6 episodes (range 2 to 7) of 
transient ST segment elevation before rt-PA administration 
(duration 9.6 _+ 1.3 rain, range 2 to 33), and the interval 
between episodes was 8 ± 2 min (range 2 to 52). In both 
groups combined, intermittent episodes occurred after rt-PA 
administration in only 10 patients: 4 received the infusion 
regimen (2.5 _+ 0.3/patient), 6 the multiple-bolus regimen 
(2.3 _+ 0.2/patient) and none the single-bolus regimen. Table 1 
shows selected baseline and short-term follow-up characteris- 
tics of the two groups. 
Left ventricular function. Left ventricular ejection fraction 
at 90 rain after rt-PA administration was 62.9 + 4% in group 
1 and 51.1 ± 5% in group 2 (p < 0.04). 
Table l. Clinical Characteristics of the Two Study Groups 
Group 1 Group 2 p 
(n = 28) (n = 29) Value 
Age (yr) 57 + 2 59 -+ 2 0.2 
Gender (M/F) 19/9 24/5 0.16 
Previous myocardial infarction 3 1 0.1 
First blood sample collection 15/13 13/16 0.77 
(AM/PM) 
Yimc from onset of pain to 197 - 16 186 _+ 15 0.63 
thrombolysis (rain) 
Mode of rt-PA administration 23/5 22/7 0.2 
(bolus/infusion) 
IRCA (LCA or LCx/RCA) 13/15 13/16 0.54 
Collateral filling of 1RCA at 4 5 0.4 
the 90-min angiogram 
Patency of IRCA at 90 rain 19/9 18/11 0.55 
(patent/occluded) 
TIMI status of IRCA at 18/1{) 16/13 0.23 
91) rain (3/2, 1, 0) 
Time to 50% resolution of 273 -+ 85 399 -+ 588 0.39 
ST segment elevation 
(recanalization time) (min) 
Data presented are mean value _+ SEM or number of patients. AM = 
midnight to 11:59 AM; F = female; Group 1 (Group 2) = patients with 
intermittent (persistent) infarct-related coronary artery (IRCA) occlusion; LCA 
or LCx - left anterior descending or circumflex coronary artery; M = male; 
occluded Thrombolysis in Myocardial Infarction (TIMI) grade 0 or 1 flow; 
patent = T1MI grade 2 or 3 flow; PM = noon to 11:59 PM; RCA = right coronary 
artery; rt-PA = recombinant tissue-type plasminogen activator. 
Plasma CK-MB levels. Plasma CK-MB level averaged over 
the first 24 h, integrated over the first 24 h, peak level and time 
to peak level were 83.5 _+ 16.8 and 125.5 _ 12.7 IU/liter (p < 
0.003), 2436 ± 538 and 3436 ___ 380 IU/liter x 24 h (p = 0.43), 
141.9 _+ 28.3 and 203.8 _ 23.3 IU/liter (p < 0.014) and 10.6 +_ 
1.0 and 9.6 _+ 1.0 h (p < 0.52) in groups 1 and 2, respectively. 
The plasma CK-MB levels measured every 6 h over the first 
24 h in the two groups are shown in Figure 2. 
Plasma C-reactive protein levels. The plasma levels of 
C-reactive protein on admission and at 1, 2 and 3 days in 
groups 1 and 2 were, respectively, 5.1 _+ 2 and 5.5 -+ 3, 16 _+ 4 
Figure 2. Plasma creatine kinase, MB isoenzyme fraction (CK MB) 
activity measured every 6 h over the first 24 h in the two study groups. 
Values shown are medians and confidence intervals (group compari- 
son by repeated measures analysis of variance, p = 0.01l). 
'~ o- / 
o 
I Group 2 o 
6 12 18 24 
Hours post admission 
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Table 2. Hemostatic Factor Levels Before Thrombolytic and 
Anticoagulant Treatment 
Group 1 Group 2 p 
(n = 28) (n -: 29) Value 
Prothrombin fragment 1.86 (1.37-2.32) 1.1 (0.75-1.46) 0.003 
FI +2 (nmol/liter) 
Soluble fibrin (nmol/ 66.8 (32.6-86.7) 31 (23.9-41.8) 0.01 
liter) 
Plasminogen activator 25.2 (13.2-31) 24 (16.1-33.1) 0.54 
inhibitor-I antigen 
0~g/liter) 
Tissue-type plasminogen 15.6 (6.3-24.1) 27 (15.2-38.3) 0.006 
activator antigen (gg/ 
liter) 
Data presented are median value (95% confidence interval). Group com- 
parison by Mann-Whitney U test. 
and 28 -+ 4, 26,6 __ 5.5 and 61.8 *- 14.4, and 19,6 + 4.2 and 
40.6 _+ 6.5 rng/liter (p < 0.012). 
Hemostatic factor levels before fibrinolytic and anticoagu- 
lant treatment. Pretreatment plasma levels of prothrombin 
fragment F1+2 and plasma soluble fibrin were significantly 
higher in group 1 than in group 2 (Table 2) Plasma PAL1 
antigen levels were similar in the two groups, but the t-PA 
antigen level was significantly lower in group 1 than in group 2 
(Table 2). 
Discuss ion  
The results of the present study show that spontaneous 
intermittent reperfusion in patients with evolving myocardial 
infarction leads to lower plasma t-PA antigen levels and a 
lesser degree of myocardial damage than in patients with 
persistent infarct-related artery occlusion and causes greater 
thrombogenic activity. This augmented thrombogenic activity 
is probably a direct consequence of the intermittency. 
Early spontaneous intermittent reperfusion and myocar- 
dial protection. Spontaneous intermittent reperfusion was as- 
sessed by computerized ST segment analysis of continuous 
ECG recordings. It has previously been demonstrated (2,3) 
that in the early hours of infarct evolution, ST segment 
elevation indicates complete occlusion of the infarct-related 
artery and resolution of ST segment elevation to baseline 
indicates patency with a variable degree of stenosis. The extent 
of myocardial infarction was assessed by three independent 
methods: myocardial enzyme release, magnitude of the acute 
phase response and left ventricular ejection fraction. 
Enzyme levels. Serial measurements of enzymes released by 
necrotic myocardium, particularly CK (16) and its MB isoen- 
zyme (17), are helpful in determining myocardial infarct size. 
In the present study the peak level, 24-h mean and plasma 
CK-MB activity measured every 6 h were lower in the inter- 
mittent han the persistent coronary occlusion group, indicat- 
ing less extensive myocardial damage (Fig. 2). Measurements 
of plasma CK-MB levels between 1 and 2 h were used in the 
original validation of this method of estimating (16) infarct 
size. However, peak CK-MB levels have also been found (18) 
to reflect the amount of myocardial damage. Although peak 
CK-MB levels could have been increased in our group of 
patients with intermittent occlusion by spontaneous reperfu- 
sion with increased washout of the enzyme, any adjustment of 
the results to compensate for this effect would accentuate he 
already significant difference between the two groups. We 
compared the mean of the 6-hourly CK-MB levels in the two 
groups, and the result was also significantly lower in the group 
with early intermittent occlusion. The integral of the CK-MB 
curve shows a lower value in the intermittent occlusion group, 
but the difference was not statistically significant. 
C-reactive protein levels. The generation and release of 
C-reactive protein is a systemic response to myocardial injury 
(19). The relation of C-reactive protein to infarct size has been 
reported previously (20), and a larger infarct results in a 
greater increase in plasma C-reactive protein. Elevation of 
C-reactive protein levels could have been due to factors other 
than infarction, including pericarditis, but these were not 
found in our patients. Furthermore, the increase in C-reactive 
protein correlated positively with changes in the other indexes 
of myocardial damage. Measurement of left ventrieular ejec- 
tion fraction is a sensitive method of estimating the extent of 
myocardial necrosis (14). Patients with spontaneous intermit- 
tent reperfusion had a higher ejection fraction at 90 rain after 
thrombolysis than those with persistent coronary occlusion. 
ST segment elevation. There was a trend toward less dura- 
tion of persistent ST segment elevation in the intermittent 
compared with the noninterrnittent group, but the difference 
was not statistically significant. Therefore, although, it is 
possible that the ischemia of lesser duration contributed to the 
difference in myocardial infarct size, a protective ffect of 
intermittency is a more likely explanation. Indeed, evidence of 
a protective ffect of anterograde flow has been provided by a 
recent study (21) that found that anterograde flow before early 
angioplasty in patients with acute myocardial infarction was 
associated with a smaller subsequent infarct size. However, the 
mechanism of this protective ffect on the rnyocardium is 
unclear. The intermittency may have salvaged rnyocardium by 
providing intermittent spontaneous reperfusion of the isch- 
emic myocardiurn early in the evolution of the infarct by 
promoting earlier persistent reperfusion i  response to throm- 
bolytic therapy or by the protective ffect of transient ischemia 
known as ischemic preconditioning (6-8). Furthermore, col- 
lateral supply, known to have protective ffect (22), might have 
been better in the intermittent group. Earlier or more frequent 
reperfusion in response to thrombolytic therapy is unlikely 
because the recanalization time (time to 50% resolution of ST 
elevation and time to peak CK-MB levels) and 90-rnin patency 
rates in both groups were comparable. There was no difference 
in the presence of collateral vessels in the infarct region in the 
two groups at 90 rain, although the absence of angiography 
before rt-PA administration represents a limitation in this 
respect and prevents a clear evaluation of the possible role of 
collateral vessels. The most likely explanation for a lesser 
degree of myocardial damage in the group with spontaneous 
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intermittent reperfusion is that the spontaneous early reperfu- 
sion provided oxygen to the jeopardized ischemic myocardium, 
precluding necrosis of the tissue, or that the associated spon- 
taneous intermittent episodes of ischemia due to coronary 
reocclusion preconditioned the myocardium, making it less 
susceptible tothe effects of prolonged coronary occlusion. This 
phenomenon may underlie the association between late pa- 
tency of an infarct-related artery and a more favorable prog- 
nosis (23), with late patency identifying a subset of patients in 
which early intermittency was present. It remains possible that 
those patients with persistent occlusion were in this state for a 
period of unknown duration before hospital admission, reflect- 
ing different rates of evolution of acute infarction. 
With regard to ischemic preconditioning, previous tudies 
(6-8) have shown that animals subjected to episodes of 
myocardial ischemia separated by reperfusion develop less 
necrosis after continuous i chemia than control animals. One 
5-min period of ischemia was sufficient o induce this protec- 
tive state in dogs and rabbits (7), but periods of ischemia <90 s 
in duration were insufficient (8). The average duration of 
intermittent episodes of ST segment elevation, indicating 
myocardial ischemia and coronary occlusion, before continu- 
ous ST segment elevation was 9.6 rain in the present study and 
would therefore have been sufficient o induce ischemic pre- 
conditioning in these patients. For obvious reasons the optimal 
duration of preconditioning ischemia is unknown in the setting 
of myocardial infarction in humans, but a recent study (10) 
demonstrated that two 3-min episodes of ischemia were suffi- 
cient to induce preconditioning during coronary artery bypass 
surgery. 
More extensive myocardial damage has been reported in 
patients showing intermittent occlusion after thrombolysis 
(24,25). However, these studies did not investigate intermit- 
tency before treatment. Intermittency was less frequent after 
than before thrombolytic treatment in our study and probably 
had less impact on infarct size because it occurred later and 
was less frequent. The different significance of early and late 
coronary recanalization with respect to infarct size, particularly 
the lesser but definite impact of late patency has been dis- 
cussed in detail by Yiefenbrunn and Sobel (23). 
Early spontaneous intermittent reperfusion and hemo. 
static changes. The F1 +2 fragment of prothrombin iscleaved 
during the conversion of prothrombin to thrombin, and there- 
fore its plasma level indicates the amount of thrombin gener- 
ated (26). Similarly, soluble fibrin is the product of the action 
of thrombin on fibrinogen, and its plasma level is an indicator 
of thrombin activity and the amount of fibrinogen conversion 
(27). Taken together these plasma levels can be used to 
measure the activity of the final stages of the coagulation 
mechanism. The results of the present study show that patients 
with spontaneous intermittent coronary occlusion have a 
higher pretreatment level of coagulation activity. This finding 
suggests that intermittent reperfusion is thrombogenic. The 
procoagulant s imulus could be located in the infarct-related 
epicardial artery, at the site of the occluding thrombus and 
atheromatous plaque or downstream in the coronary, micro- 
vasculature and ischemic myocardium. In the epicardial arte- 
rial segment, he interaction between reflowing blood and the 
residual thrombus (28) or the subendothelial collagen exposed 
by the disrupted atheroma could trigger local platelet activa- 
tion (29) and release prothrombotic ompounds, such as 
thromboxane A 2 (4) or thrombin (5). Furthermore, the in- 
creased thrombogenic a tivity may be a result of spontaneous 
lysis underlying the intermittency. Downstream, in the infarct- 
related coronary vascular bed, microvascular or myocardial 
damage induced by ischemia or reperfusion, or both, might 
also activate coagulation within the reperfusing blood. 
In the presence of greater coagulation activity, the group of 
patients with spontaneous intermittent myocardial reperfusion 
had lower t-PA antigen levels. Higher fibrinolytic activity might 
have been expected in this group to explain the spontaneous 
early reopening of the occluded arteries. However, although 
increase in PAI-1 activity due to platelet activation during 
thrombosis and thrombolysis has been reported in experimen- 
tal animals (30), there was no difference in PAI-1 antigen levels 
between the groups, and therefore, although the activities of 
t-PA and PAI-1 were not measured, it is unlikely that fibrino- 
lytic activity was higher in the intermittent group. Tissue-type 
plasminogen activator antigen is constitutively produced by 
endothelial cells. Its plasma concentrations are subject o a 
circadian variation (31), are age related (32) and can increase 
rapidly in response to catecholamines (33) or to a reduction in 
liver blood flow and hepatic learance (34). The time of day of 
the pretreatment blood samples and age were not significantly 
different in the two patient groups (Table 1). It is possible that 
the lower t-PA antigen levels in the intermittent coronary 
occlusion group reflect a better hemodynamic state with less 
sympathetic activation, consistent with less extensive myocar- 
dial damage. The results of the present study do not exclude 
higher local fibrinolytic activity at the site of the epicardial 
coronary thrombus in patients with early intermittent occlu- 
sion. It is possible that more t-PA is bound to fibrin in freshly 
generated clots or to newly exposed binding sites in this group, 
leading to increased plasmin generation and local fibrinolysis 
and possibly resulting in a reduction in circulating t-PA antigen 
levels. Furthermore, it has been shown (5,35-38) that plasmin 
can activate coagulation factors and platelets, causing an 
augmentation f the procoagulant s ate. Therefore, the greater 
coagulant activity may be a consequence of the reopening of 
the artery, intensifying the possibility of reocclusion. 
Although the present results suggest hat patients with 
intermittent coronary occlusion have more active thrombin 
formation, the fundamental difference between the two groups 
may lie only in the phase of infarct evolution in which the 
measurements were taken. There was no significant difference 
in the interval between the onset of symptoms and blood 
sampling between the two groups. It is therefore possible that 
intermittency of coronary occlusion identifies a group of 
patients in whom the evolution of infarction is relatively slow 
so that the initial thrombogenic stimulus persists into the early 
hours of hospital admission. Conversely, persistent ST segment 
elevation may indicate rapid evolution of the process of 
JACC Vol. 26, No. 3 HAIDER ET AL. 667 
September 1995:662-7 SPONTANEOUS CORONARY RECANALIZATION DURING INFARCTION 
coronary thrombosis and myocardial infarction so that by the 
time of hospital admission the process is advanced or com- 
plete, and the thrombogenic stimulus has waned. Alternatively, 
patients with intermittency may be those in whom initial 
endogenous fibrinolytic activity is sufficient o produce spon- 
taneous lysis and set the stage for additional spontaneous 
thrombosis. 
Conclusions. Spontaneous intermittent myocardial reper- 
fusion before thrombolytic treatment in the early phase of 
myocardial infarction in patients is associated with greater 
thrombogenic activity and a smaller subsequent infarct size 
than those with early persistent coronary occlusion. These 
findings may reflect different rates of evolution of coronary 
thrombosis and myocardial infarction. They also provide evi- 
dence that intermittent ischemia and reperfusion stimulate 
thrombin generation and confer myocardial protection. A 
better understanding of mechanisms responsible for spontane- 
ous coronary reperfusion will help to improve thrombolytic 
therapy and patient prognosis. 
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